Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-55308942 是 P2X7 功能性的选择性脑渗透拮抗剂,对 hP2X7 和 rP2X7 的 IC50 分别为 10 和 15 nM,Kis 分别为 7.1 和 2.9 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 729 | 现货 | ||
5 mg | ¥ 1,730 | 现货 | ||
10 mg | ¥ 2,820 | 现货 | ||
25 mg | ¥ 4,760 | 现货 | ||
50 mg | ¥ 6,780 | 现货 | ||
100 mg | ¥ 9,180 | 现货 | ||
500 mg | ¥ 18,300 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,920 | 现货 |
产品描述 | JNJ-55308942 is a selective and brain-penetrant antagonist of P2X7 functional with IC50s of 10 and 15 nM and Kis of 7.1 and 2.9 nM for hP2X7 and rP2X7, respectively. |
体外活性 | JNJ-55308942 shows pKis of 8.1and 8.5 for recombinant hP2X7 and rP2X7. JNJ-55308942 attenuates IL-1β release in a concentration-dependent manner in human blood and in mouse blood and microglia[2]. |
体内活性 | JNJ-55308942 (5 mg/kg; p.o.) shows the F of 81%, Vss of 1.7 L/kg, CL of 1.7 L/kg, Cmax of 3.7 mL min/kg, and AUC of 1747 ng/mL[1]. In male C57/BL6J mice, JNJ-55308942 (30 mg/kg; p.o.) significantly attenuates the effect of LPS on FSC, CD45 surface expression, and CD11b surface expression. In a model of Bacillus Calmette-Guerin-induced depression, JNJ-55308942 (30 mg/kg; orally) reverses the BCG-induced deficits of sucrose preference and social interaction (ED50 = 0.07 mg/kg). The P2X7 antagonist (3 mg/kg, orally) blocks Bz-ATP-induced brain IL-1β release in conscious rats[2]. |
分子量 | 425.32 |
分子式 | C17H12F5N7O |
CAS No. | 2166558-11-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90 mg/mL (211.6 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.3512 mL | 11.7559 mL | 23.5117 mL | 58.7793 mL |
5 mM | 0.4702 mL | 2.3512 mL | 4.7023 mL | 11.7559 mL | |
10 mM | 0.2351 mL | 1.1756 mL | 2.3512 mL | 5.8779 mL | |
20 mM | 0.1176 mL | 0.5878 mL | 1.1756 mL | 2.939 mL | |
50 mM | 0.047 mL | 0.2351 mL | 0.4702 mL | 1.1756 mL | |
100 mM | 0.0235 mL | 0.1176 mL | 0.2351 mL | 0.5878 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
JNJ-55308942 2166558-11-6 Membrane transporter/Ion channel Neuroscience P2X Receptor JNJ 55308942 JNJ55308942 Inhibitor inhibitor inhibit